Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2019

Nov 27, 2019

32845_dirs_2019-11-27_6aa7a5bb-82b7-4c7f-a456-88c9d371881c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-11-25

Reporting Person: OLSON CHARLES W (Senior VP of Bus Dev, Med Dev)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-25 Common Stock A 7852 $0.00 Acquired 42092 Direct
2019-11-25 Common Stock F 3581 $42.00 Disposed 38511 Direct
2019-11-25 Common Stock A 3095 $0.00 Acquired 41606 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-11-25 Employee Stock Option (right to buy) $42.00 A 13579 Acquired 2026-11-25 Common Stock (13579) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 800 Indirect

Footnotes

F1: Performance shares awarded under long-term incentive plan based on performance during three-year period ended September 30, 2019.

F2: Shares withheld to satisfy taxes incident to vesting of performance share award.

F3: The award vests in four equal installments on each of the first four anniversaries of the November 25, 2019 grant date.